1P5Z | B: | STRUCTURE OF HUMAN DCK COMPLEXED WITH CYTARABINE AND ADP-MG |
1P60 | A:; B: | STRUCTURE OF HUMAN DCK COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, SPACE GROUP C 2 2 21 |
1P61 | B: | STRUCTURE OF HUMAN DCK COMPLEXED WITH 2'-DEOXYCYTIDINE AND ADP, P 43 21 2 SPACE GROUP |
1P62 | B: | STRUCTURE OF HUMAN DCK COMPLEXED WITH GEMCITABINE AND ADP-MG |
2A2Z | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN DEOXYCYTIDINE KINASE IN COMPLEX WITH DEOXYCYTIDINE AND URIDINE DIPHOSPHATE |
2A30 | A:; B:; C:; D: | CRYSTAL STRUCTURE OF HUMAN DEOXYCYTIDINE KINASE IN COMPLEX WITH DEOXYCYTIDINE |
2A7Q | A: | CRYSTAL STRUCTURE OF HUMAN DCK COMPLEXED WITH CLOFARABINE AND ADP |
2NO0 | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH GEMCITABINE+ADP |
2NO1 | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH D-DC+ADP |
2NO6 | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH FTC+ADP |
2NO7 | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH L-DC+ADP |
2NO9 | A:; B: | THE STRUCTURE OF DEOXYCYTIDINE KINASE COMPLEXED WITH TROXACITABINE AND ADP. |
2NOA | A:; B: | THE STRUCTURE OF DEOXYCYTIDINE KINASE COMPLEXED WITH LAMIVUDINE AND ADP. |
2QRN | A:20-260; B:20-260; C:20-260; D:20-260 | HUMAN DEOXYCYTIDINE KINASE DCMP, UDP, MG ION PRODUCT COMPLEX |
2QRO | A:20-260; B:20-260; C:20-260; D:20-260 | HUMAN DEOXYCYTIDINE KINASE DAMP, UDP, MG ION PRODUCT COMPLEX |
2ZI3 | A:; B: | C4S-E247A DCK VARIANT OF DCK IN COMPLEX WITH D-DA+ADP |
2ZI4 | A: | C4S DCK VARIANT OF DCK IN COMPLEX WITH L-DA+ADP |
2ZI5 | A:; B:; C:; D: | C4S DCK VARIANT OF DCK IN COMPLEX WITH L-DA+UDP |
2ZI6 | A:; B:; C:; D: | C4S DCK VARIANT OF DCK IN COMPLEX WITH D-DA+UDP |
2ZI7 | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH D-DG+UDP |
2ZI9 | A:; B: | C4S-E247A DCK VARIANT OF DCK IN COMPLEX WITH CLADRIBINE+ADP |
2ZIA | A:; B: | C4S DCK VARIANT OF DCK IN COMPLEX WITH CLADRIBINE+UDP |
3HP1 | A: | CRYSTAL STRUCTURE OF HUMAN DCK R104M/D133A IN COMPLEX WITH L-DT AND ADP |
3IPX | A: | X-RAY STRUCTURE OF HUMAN DEOXYCYTIDINE KINASE IN COMPLEX WITH ADP AND AN INHIBITOR |
3IPY | A:; B: | X-RAY STRUCTURE OF HUMAN DEOXYCYTIDINE KINASE IN COMPLEX WITH AN INHIBITOR |
3KFX | A:; B: | HUMAN DCK COMPLEX WITH 5-ME DC AND ADP |
3MJR | A:; B:; C:; D: | HUMAN DCK COMPLEX WITH ACYCLIC NUCLEOSIDE |
3QEJ | A:; B: | S74E-DCK MUTANT IN COMPLEX WITH UDP |
3QEN | A:; B: | S74E DCK IN COMPLEX WITH 5-BROMODEOXYCYTIDINE AND UDP |
3QEO | A:; B: | S74E-R104M-D133A DCK VARIANT IN COMPLEX WITH L-DEOXYTHYMIDINE AND UDP |
4JLJ | A:; B: | HUMAN DCK C4S-S74E MUTANT IN COMPLEX WITH UDP AND THE F2.1.1 INHIBITOR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE) |
4JLK | A:; B: | HUMAN DCK C4S-S74E MUTANT IN COMPLEX WITH UDP AND THE F2.2.1 INHIBITOR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-METHYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE) |
4JLM | A:; B: | HUMAN DCK C4S-S74E MUTANT IN COMPLEX WITH UDP AND THE F2.3.1 INHIBITOR (2-[({5-ETHYL-2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE) |
4JLN | A:; B: | HUMAN DCK C4S-S74E MUTANT IN COMPLEX WITH UDP AND THE F2.4.1 INHIBITOR (2-[({2-[3-(2-FLUOROETHOXY)-4-METHOXYPHENYL]-5-PROPYL-1,3-THIAZOL-4-YL}METHYL)SULFANYL]PYRIMIDINE-4,6-DIAMINE) |
4L5B | A:; B: | HUMAN DCK C4S-S74E MUTANT IN COMPLEX WITH UDP AND THE DI-43 INHIBITOR |